Aligos therapeutics to present at the jefferies virtual healthcare conference

South san francisco, calif., may 20, 2021 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that lawrence blatt, ph.d., mba, ceo of aligos, will present at the jefferies virtual healthcare conference being held june 1- 4, 2021. the presentation will be followed by a virtual q&a session.
ALGS Ratings Summary
ALGS Quant Ranking